The South African government has suspended the launch of the Oxford-AstraZeneca vaccine after a study showed “disappointing” results for a new generation of coronavirus.
Scientists say the new strain of corona virus is now 90% in the country.The study, which involved 2,000 people, found that the vaccine was “less protective than the new corona virus.”
1 million AstraZeneca vaccines have been delivered to South Africa and are expected to begin next week.
South African Health Minister Zweli Mkhize told a news conference that the government was awaiting further recommendations on how to proceed with the Oxford-AstraZeneca vaccine in light of the findings of the study.
